Springboard will offer products for companies looking to develop biological therapies (gene therapy, antibodies, enzymes). The platform allows to transition customers from R&D to market with a quick, efficient and commercially viable process, reducing cost and time.

Currently companies in the field all have to develop their own processes and assays to get to commercial scale and grades - often with legacy processes due to lack of expertise and budgeting for what up-to-date technology development would require and the resulting costly equivalency studies. Springboard will offer a platform of turnkey products and processes for any stage so companies can finally focus on their therapeutic development. The market is estimated to be $17.9 billion in 2023. Springboard would be profitable within 24 month and the estimated revenue in 2025 is (conservative estimate) over $70 million dollar with the first product. I have a proof of concept for the first product, IP filed and am currently wor...
Springboard will offer products for companies looking to develop biological therapies (gene therapy, antibodies, enzymes). The platform allows to transition customers from R&D to market with a quick, efficient and commercially viable process, reducing cost and time.

Currently companies in the field all have to develop their own processes and assays to get to commercial scale and grades - often with legacy processes due to lack of expertise and budgeting for what up-to-date technology development would require and the resulting costly equivalency studies. Springboard will offer a platform of turnkey products and processes for any stage so companies can finally focus on their therapeutic development. The market is estimated to be $17.9 billion in 2023. Springboard would be profitable within 24 month and the estimated revenue in 2025 is (conservative estimate) over $70 million dollar with the first product. I have a proof of concept for the first product, IP filed and am currently working on a pre-product licensing agreement with a first customer.

The company is currently in pre-seed stage. I am looking for a co-founder who has a background in business development, preferentially startup founding and VC fundraising experience, ideally even in the field of biotech (cell and gene therapy). MBA would be a plus. My co-founder should be able to bootstrap at least until September (salary upon funding) but does not need to be available fulltime. He/she should be local and timewise flexible and able to travel though (pitching).
More information

Employees

Ulrike Jung
Admin

Join the team